Based on the binary logistic regression of gene polymorphisms TEP1 rs1760904, rs1713418, and TERC rs12696304, individuals younger than 44 years with MS and the control group showed no statistically significant differences. This evidence concerns the gene TEP1 and myeloid sarcoma.